Following in Florida’s footsteps comes another state that is working around a federal clampdown on alternative COVID-19 treatments by working directly with providers.
This afternoon Texas Gov. Greg Abbott went on Dana Loesch’s radio program to announce that his state has secured their own COVID antibody treatments separate from the limitations imposed by the Biden administration.
"Texas has obtained its own separate allocation of these monoclonal antibody therapeutic treatments, working around the limitation that President Biden put on us," Abbott said. "So that we will be able to ensure that anybody in the state of Texas that wants access to these special treatments, that they will be able to get it."
Abbott continued: "In order to get these monoclonal antibody therapeutic treatments, you do need to test positive for COVID. But if you do, this is a way of getting a treatment in a way that you will not (most likely) not be hospitalized, or have to go to a hospital or anything like that."
Dana Loesch responded by saying it was great news given how the Biden administration’s restriction policies didn’t make it clear how states could access the federal supplies.
The rest of the Abbott interview had him talking with Dana about the border situation and the governor's pledge to protect the careers of border agents if the Biden administration punished them for carrying out their jobs.
When it comes to precedent for the monoclonal antibody story, the state of Florida had embarked on a similar workaround. It was two weeks ago that the Biden administration took over the supply chain of this COVID therapy treatment in what they called as being for more "equitable distribution."
It was on Thursday of last week that Florida Governor Ron DeSantis announced his successful arrangement with obtaining GlaxoSmithKline’s Sotrovimab.